Defining distal splenopancreatectomy by the mesopancreas.
CRM
Distal pancreatectomy
Ductal adenocarcinoma of the pancreas
Mesopancreatic excision
PDAC
Pancreatic cancer
Peripancreatic tissue
Survival outcome
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
received:
16
01
2024
accepted:
10
04
2024
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
16
4
2024
Statut:
epublish
Résumé
The implementation of the pathologic CRM (circumferential resection margin) staging system for pancreatic head ductal adenocarcinomas (hPDAC) resulted in a dramatic increase of R1 resections at the dorsal resection margin, presumably because of the high rate of mesopancreatic fat (MP) infiltration. Therefore, mesopancreatic excision (MPE) during pancreatoduodenectomy has recently been promoted and has demonstrated better local disease control, fueling the discussion of neoadjuvant downsizing regimes in MP + patients. However, it is unknown to what extent the MP is infiltrated in patients with distal pancreatic (tail/body) carcinomas (dPDAC). It is also unknown if the MP infiltration status affects surgical margin control in distal pancreatectomy (DP). The aim of our study was to histopathologically analyze MP infiltration and elucidate the influence of resection margin clearance on recurrence and survival in patients with dPDAC. Furthermore, the results were compared to a collective receiving MPE for hPDAC. Clinicopathological and survival parameters of 295 consecutive patients who underwent surgery for PDAC (n = 63 dPDAC and n = 232 hPDAC) were evaluated. The CRM evaluation was performed in a standardized fashion and the specimens were examined according to the Leeds pathology protocol (LEEPP). The MP area was histopathologically evaluated for cancerous infiltration. In 75.4% of dPDAC patients the MP fat was infiltrated by vital tumor cells. The rates of MP infiltration and R0CRM- resections were similar between dPDAC and hPDAC patients (p = 0.497 and 0.453 respectively). MP- infiltration status did not correlate with CRM implemented resection status in dPDAC patients (p = 0.348). In overall survival analysis, resection status and MP status remained prognostic factors for survival. In follow up analysis. surgical margin clearance in dPDAC patients was associated with a significant improvement in local recurrence rates (5.2% in R0CRM- resected vs. 33.3 in R1/R0CRM + resected, p = 0.002). While resection margin status was not affected by the MP status in dPDAC patients, the high MP infiltration rate, as well as improved survival in MP- dPDAC patients after R0CRM- resection, justify mesopancreatic excision during splenopancreatectomy. Larger scale studies are urgently needed to validate our results and to study the effect on neoadjuvant treatment in dPDAC patients.
Sections du résumé
BACKGROUND
BACKGROUND
The implementation of the pathologic CRM (circumferential resection margin) staging system for pancreatic head ductal adenocarcinomas (hPDAC) resulted in a dramatic increase of R1 resections at the dorsal resection margin, presumably because of the high rate of mesopancreatic fat (MP) infiltration. Therefore, mesopancreatic excision (MPE) during pancreatoduodenectomy has recently been promoted and has demonstrated better local disease control, fueling the discussion of neoadjuvant downsizing regimes in MP + patients. However, it is unknown to what extent the MP is infiltrated in patients with distal pancreatic (tail/body) carcinomas (dPDAC). It is also unknown if the MP infiltration status affects surgical margin control in distal pancreatectomy (DP). The aim of our study was to histopathologically analyze MP infiltration and elucidate the influence of resection margin clearance on recurrence and survival in patients with dPDAC. Furthermore, the results were compared to a collective receiving MPE for hPDAC.
METHOD
METHODS
Clinicopathological and survival parameters of 295 consecutive patients who underwent surgery for PDAC (n = 63 dPDAC and n = 232 hPDAC) were evaluated. The CRM evaluation was performed in a standardized fashion and the specimens were examined according to the Leeds pathology protocol (LEEPP). The MP area was histopathologically evaluated for cancerous infiltration.
RESULTS
RESULTS
In 75.4% of dPDAC patients the MP fat was infiltrated by vital tumor cells. The rates of MP infiltration and R0CRM- resections were similar between dPDAC and hPDAC patients (p = 0.497 and 0.453 respectively). MP- infiltration status did not correlate with CRM implemented resection status in dPDAC patients (p = 0.348). In overall survival analysis, resection status and MP status remained prognostic factors for survival. In follow up analysis. surgical margin clearance in dPDAC patients was associated with a significant improvement in local recurrence rates (5.2% in R0CRM- resected vs. 33.3 in R1/R0CRM + resected, p = 0.002).
CONCLUSION
CONCLUSIONS
While resection margin status was not affected by the MP status in dPDAC patients, the high MP infiltration rate, as well as improved survival in MP- dPDAC patients after R0CRM- resection, justify mesopancreatic excision during splenopancreatectomy. Larger scale studies are urgently needed to validate our results and to study the effect on neoadjuvant treatment in dPDAC patients.
Identifiants
pubmed: 38625602
doi: 10.1007/s00423-024-03320-0
pii: 10.1007/s00423-024-03320-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
127Informations de copyright
© 2024. The Author(s).
Références
Malleo G, Maggino L, Ferrone CR, Marchegiani G, Luchini C, Mino-Kenudson M et al (2020) Does site Matter? impact of tumor location on pathologic characteristics, recurrence, and survival of resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 27(10):3898–912
Andrén-Sandberg Å, Wagner M, Tihanyi T, Löfgren P, Friess H (1999) Technical aspects of left-sided pancreatic resection for cancer. Dig Surg 16(4):305–312
doi: 10.1159/000018740
pubmed: 10449975
Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15(6):1651–1660
doi: 10.1245/s10434-008-9839-8
pubmed: 18351300
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93(10):1232–1237
doi: 10.1002/bjs.5397
pubmed: 16804874
Schlitter E (2010) Definition of microscopic tumor clearance (R0) in pancreatic cancer resections. Cancers 2:2001–2010
doi: 10.3390/cancers2042001
pubmed: 24281214
pmcid: 3840457
Häberle L, Esposito I (2020) Circumferential resection margin (CRM) in pancreatic cancer. Surg Pract Sci 1:100006
doi: 10.1016/j.sipas.2020.100006
Safi SA, Haeberle L, Fluegen G, Lehwald-Tywuschik N, Krieg A, Keitel V, Luedde T, Esposito I, Rehders A, Knoefel WT (2021) (2021) Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Pancreatology 21(4):787–795
Safi SA, Haeberle L, Esposito I, Knoefel WT (2023) Mesopanc-01-Studie zum Pankreaskopfkarzinom. Forum 38(2):152–156
doi: 10.1007/s12312-023-01186-9
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482
doi: 10.1016/S0140-6736(86)91510-2
pubmed: 2425199
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis 11(4):354–64 discussion 64-5
doi: 10.1111/j.1463-1318.2008.01735.x
pubmed: 19016817
Croner RS, Ptok H, Merkel S, Hohenberger W (2018) Implementing complete mesocolic excision for colon cancer - mission completed? Innov Surg Sci 3(1):17–29
pubmed: 31579762
pmcid: 6754049
Toldt C (1897) Lehrbuch der Anatomie des Menschen. 6th Edition ed: Wilhelm Braumueller K. K. Hofbuchhaendler
Nakamura T, Hirano S, Noji T, Asano T, Okamura K, Tsuchikawa T et al (2016) Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for locally advanced pancreatic body cancer: A single-center review of 80 consecutive patients. Ann Surg Oncol 23(Suppl 5):969–975
doi: 10.1245/s10434-016-5493-8
pubmed: 27495282
Collard M, Marchese T, Guedj N, Cauchy F, Chassaing C, Ronot M et al (2019) Is routine splenectomy justified for all left-sided pancreatic cancers? Histological reappraisal of splenic hilar lymphadenectomy. Ann Surg Oncol 26(4):1071–1078
doi: 10.1245/s10434-018-07123-8
pubmed: 30607766
Ricci C, Casadei R, Taffurelli G, Pacilio CA, Minni F (2016) Laparoscopic distal pancreatectomy: many meta-analyses, few certainties. Updates Surg 68(3):225–234
doi: 10.1007/s13304-016-0389-5
pubmed: 27605207
Zhang H, Lan X, Peng B, Li B (2019) Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis. World J Gastroenterol 25(37):5711–5731
doi: 10.3748/wjg.v25.i37.5711
pubmed: 31602170
pmcid: 6785520
Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133(5):521–527
doi: 10.1067/msy.2003.146
pubmed: 12773980
Strasberg SM, Linehan DC, Hawkins WG (2007) Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: Ability to obtain negative tangential margins. J Am Coll Surg 204(2):244–249
doi: 10.1016/j.jamcollsurg.2006.11.002
pubmed: 17254928
Kwon J, Park Y, Jun E, Lee W, Song KB, Lee JH, Hwang DW, Kim SC (2021) Clinical outcome of RAMPS for left-sided pancreatic ductal adenocarcinoma: a comparison of anterior RAMPS versus posterior RAMPS for patients without periadrenal infiltration. Biomedicines 9(10):1291
Sham JG, Guo S, Ding D, Shao Z, Wright M, Jing W et al (2020) Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysis. Chin Clin Oncol 9(4):54
doi: 10.21037/cco-20-6
pubmed: 32576018
Steinke H (2018) Atlas of human fascial topography: Leipziger Universitätsverlag, 2018
Popescu I, Dumitrascu T (2018) What is the value of total mesopancreas excision in pancreatic ductal adenocarcinoma? Current evidence of the literature. Chirurgia (Bucur) 113(3):335–343
doi: 10.21614/chirurgia.113.3.335
pubmed: 29981664
Nappo G, Perinel J, El Bechwaty M, Adham M (2016) The standardization of pancreatoduodenectomy: Where are we? Pancreas 45(4):493–502
doi: 10.1097/MPA.0000000000000503
pubmed: 26954493
Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T (2007) Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 5:44
doi: 10.1186/1477-7819-5-44
pubmed: 17459163
pmcid: 1865381
Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J et al (2015) Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach. Ann Surg 262(6):1092–1101
doi: 10.1097/SLA.0000000000001065
pubmed: 25587814
Peparini N, Chirletti P (2013) Mesopancreas: a boundless structure, namely R1 risk in pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 39(12):1303–1308
doi: 10.1016/j.ejso.2013.10.012
pubmed: 24188796
Reich P, Schreiber HW, Lierse W (1988) The mesoduodenum. Langenbecks Arch Chir 373(3):182–188
doi: 10.1007/BF01274231
pubmed: 2967906
Cong L, Liu Q, Zhang R, Cui M, Zhang X, Gao X et al (2018) Tumor size classification of the 8(th) edition of TNM staging system is superior to that of the 7(th) edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy. Sci Rep 8(1):10383
doi: 10.1038/s41598-018-28193-4
pubmed: 29991730
pmcid: 6039534
Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I et al (2013) S3-guideline exocrine pancreatic cancer. Z Gastroenterol 51(12):1395–1440
pubmed: 24338757
Rouviere H (1924) Anatomie Humaine Tome 1 Tete, cou et tronc
Langer C (1865) Lehrbuch der Anatomie des Menschen: Wilhelm Braumueller K. K. Hofbuchhaendler
Esposito I (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660
doi: 10.1245/s10434-008-9839-8
pubmed: 18351300
Beltzer C, Jovine E, Hesch KV, Stifini D, Mastrangelo L, Huth M et al (2022) Feasibility and outcome of spleen and vessel preserving total pancreatectomy (SVPTP) in pancreatic malignancies - a retrospective cohort study. Langenbecks Arch Surg 407(8):3457–3465
doi: 10.1007/s00423-022-02690-7
pubmed: 36169725
pmcid: 9722871
Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C et al (2017) Pancreatic cancer surgery: The new r-status counts. Ann Surg 265(3):565–573
doi: 10.1097/SLA.0000000000001731
pubmed: 27918310
Safi SA, Haeberle L, Fluegen G, Lehwald-Tywuschik N, Krieg A, Keitel V et al (2021) Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Pancreatology 21(4):787–795
doi: 10.1016/j.pan.2021.02.024
pubmed: 33775563
Demir IE, Jäger C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, Tieftrunk E, Scheufele F, Calavrezos L, Schirren R, Esposito I, Weichert W, Friess H, Ceyhan GO (2018) R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg 268(6):1058–1068